Ohio State University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ohio State University - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH68890D
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Ohio State University (Ohio State) is an educational university that offers undergraduate programs, master, doctoral and professional degree programs. The university provides research in the areas of animal care and use, business and industry, biomedical engineering, food, agricultural and environmental sciences, and others. Ohio State offers academic, arts and cultural and medical education and research through its centers of education. The university carries out technology transfer services through its technology commercialization offices. The organization operates through its campuses and research centers located across Ohio. Ohio State is headquartered in Columbus, Ohio, the US.

Ohio State University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Ohio State University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10

Ohio State University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Ohio State University, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Iovance Biotherapeutics Enters into Research Agreement with Arthur G. James Cancer Hospital & Richard J Solove Research Institute 13

Exicure Enters into Agreement with Ohio State University 14

Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 15

Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 16

Evotec Enters into Research Agreement with Ohio State University 17

Imcare Biotech Enters into Development Partnership with Ohio State University 18

Ohio State University and University of Michigan Enter into Agreement with Venture Therapeutics 19

Ohio State University Enters Into Licensing Agreement With MedVax Technologies For Cancer Peptide Vaccine 20

Biosortia Pharma Enters into Research Agreement with Ohio State University 21

National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 22

Licensing Agreements 23

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 23

Ohio State Innovation Enters into Licensing Agreement with Therapeutics Company 24

Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 25

Cellectis Enters into Licensing Agreement with Ohio State Innovation Foundation 26

The Ohio State University Enters Into Licensing Agreement With Microlin Bio 27

NewLink Genetics Enters into Licensing Agreement with Ohio State University 28

Rexahn Pharma Enters Into Licensing Agreement With Ohio State Innovation Foundation For Oligonucleotide Drug Delivery Platform 29

Asset Transactions 30

Aspen Park Pharma Acquires Worldwide Rights to APP-111 Therapy from Ohio State University 30

Ohio State University-Key Competitors 31

Ohio State University-Key Employees 32

Ohio State University-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Government and Public Interest 34

Aug 30, 2018: New program boosts use of HIV medications in injection-drug users 34

Aug 30, 2018: Research to examine how blood flow influences plaque buildup 36

May 31, 2018: Bonnie J. Addario Lung Cancer Foundation and Van Auken Private Foundation Announce the 2018 Young Innovators Team Award for Lung Cancer Research 38

Feb 26, 2018: National Colorectal Cancer Roundtable Recognizes Leaders in Colorectal Cancer Screening Efforts with 80% by 2018 National Achievement Award 39

Jan 23, 2018: Damon Runyon Cancer Research Foundation awards USD 3M to eleven innovative early career scientists 41

Dec 18, 2017: Tiny Bilirubin-filled Capsules Could Improve Survival of Transplanted Pancreatic Cells 44

Nov 30, 2017: Invasive cells in head and neck tumors predict cancer spread 45

Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 47

Sep 07, 2017: Gillings Innovation Lab Award Funds Hepatitis Prevention in Africa 48

Jun 08, 2017: Balance Gait Negatively Impacted After Chemotherapy Treatment 49

Jun 02, 2017: Drug Discovery and Development- "Immunotherapy: Training The Body to Fight Cancer" 51

May 15, 2017: Cure SMA Awards USD 75,000 Grant to Stephen J. Kolb, PhD, Ohio State University 52

May 15, 2017: USD 2.6 Million in New Grants Spurs Innovation 53

Product News 56

Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 56

Aug 06, 2018: Novel vaccine approach proves powerful against Zika virus 58

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

Ohio State University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Ohio State University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Ohio State University, Pharmaceuticals & Healthcare, Key Facts 2

Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Ohio State University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Ohio State University, Deals By Therapy Area, 2012 to YTD 2018 9

Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10

Ohio State University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Iovance Biotherapeutics Enters into Research Agreement with Arthur G. James Cancer Hospital & Richard J Solove Research Institute 13

Exicure Enters into Agreement with Ohio State University 14

Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 15

Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 16

Evotec Enters into Research Agreement with Ohio State University 17

Imcare Biotech Enters into Development Partnership with Ohio State University 18

Ohio State University and University of Michigan Enter into Agreement with Venture Therapeutics 19

Ohio State University Enters Into Licensing Agreement With MedVax Technologies For Cancer Peptide Vaccine 20

Biosortia Pharma Enters into Research Agreement with Ohio State University 21

National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 22

Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 23

Ohio State Innovation Enters into Licensing Agreement with Therapeutics Company 24

Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 25

Cellectis Enters into Licensing Agreement with Ohio State Innovation Foundation 26

The Ohio State University Enters Into Licensing Agreement With Microlin Bio 27

NewLink Genetics Enters into Licensing Agreement with Ohio State University 28

Rexahn Pharma Enters Into Licensing Agreement With Ohio State Innovation Foundation For Oligonucleotide Drug Delivery Platform 29

Aspen Park Pharma Acquires Worldwide Rights to APP-111 Therapy from Ohio State University 30

Ohio State University, Key Competitors 31

Ohio State University, Key Employees 32

Ohio State University, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Ohio State University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com